Chromocell Therapeutics Corp CHRO 深 滬
等待開盤 09-18 09:30:00 美东时间
1.35
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 1.35
- 總市值 890.45万
- 52周最高 38.00
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.50
- 委 比 0.00%
- 總股本 659.59万
- 歷史最高 60.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 4.50
- 每 手 1
- 風險率 5.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Dr. Reddy’s Laboratories Announces Resignation of CHRO
An update from Dr Reddy’s Laboratories ( ($RDY) ) is now available. Dr. Reddy’s...
09-02 19:27
The Hershey Company Appoints Natalie Rothman as Chief Human Resources Officer
Seasoned HR Executive Brings 25+ Years of Leadership Experience in Building High-Performing Teams and Modernizing HR Operations HERSHEY, Pa., Aug. 18, 2025 /PRNewswire/ -- The Hershey Compan...
08-18 22:15
Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease
Pelthos launches Zelsuvmi, the first FDA-approved at-home prescription gel for molluscum, shown to clear lesions in as little as two weeks.
07-10 20:13
Chromocell Therapeutics Merges and Becomes Pelthos Therapeutics
The latest update is out from Chromocell Therapeutics Corp ( ($CHRO) ). On July...
07-03 05:49
Channel Therapeutics Announces 10-For-1 Reverse Split Ahead Of LNHC Merger, $50M Investment Led By Murchinson
Channel Therapeutics Corporation, ("Channel" or the "Company"), (NYSE:CHRO), an emerging leader in the development of non-opioid pain treatment therapeutics, today announced a 10-for-one reverse split (the "Reverse Stock
06-27 21:17
Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement
Channel Therapeutics Corporation announced a 10-for-1 reverse stock split to increase its share price and meet NYSE American listing requirements ahead of a $50 million merger with LNHC, Inc. The split will reduce the number of outstanding shares from ~6.5 million to ~648,501, effective before market open on July 1, with trading resuming on July 2 under the name "Pelthos Therapeutics Inc." Shareholders' ownership percentages remain unchanged, and...
06-27 13:15
李宁集团与北京体育大学达成战略合作
6月15日，李宁集团与北京体育大学正式签署战略合作协议。北京体育大学党委书记樊战备、校长张剑，李宁品牌创始人、集团董事长李宁，李宁集团副总裁、CHRO宋春涛等出...
06-16 12:10
